Ilya V. Ulasov

8.4k total citations · 2 hit papers
112 papers, 4.4k citations indexed

About

Ilya V. Ulasov is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Ilya V. Ulasov has authored 112 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 49 papers in Genetics and 43 papers in Oncology. Recurrent topics in Ilya V. Ulasov's work include Virus-based gene therapy research (49 papers), RNA Interference and Gene Delivery (42 papers) and CAR-T cell therapy research (29 papers). Ilya V. Ulasov is often cited by papers focused on Virus-based gene therapy research (49 papers), RNA Interference and Gene Delivery (42 papers) and CAR-T cell therapy research (29 papers). Ilya V. Ulasov collaborates with scholars based in United States, Russia and India. Ilya V. Ulasov's co-authors include Maciej S. Lesniak, Matthew A. Tyler, Adam M. Sonabend, Elena A. Rozhkova, Tijana Rajh, Yu Han, V. Novosad, Dong‐Hyun Kim, Purvaba J. Sarvaiya and Bart Thaçi and has published in prestigious journals such as Advanced Materials, Journal of Clinical Investigation and Nature Materials.

In The Last Decade

Ilya V. Ulasov

108 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Biofunctionalized magnetic-vortex microdiscs for targeted cancer-cell destruction

2009 482 citations Ilya V. Ulasov, Maciej S. Lesniak et al. profile →
Brain Co‐Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy

2022 146 citations Ilya V. Ulasov et al. profile →

Peers

Ilya V. Ulasov

ONCOL

GENET

Atique U. Ahmed United States

E. Antonio Chiocca United States

Kathleen F. Pirollo United States

Abhijit De India

Nadia Carlesso United States

Dinorah Friedmann‐Morvinski Israel

Dwayne G. Stupack United States

Caius G. Radu United States

Byron Hann United States

Christoph Rader United States

Atique U. Ahmed United States

Ilya V. Ulasov

2.4k ×1.1

1.7k ×1.2

ONCOL

1.0k ×0.8

GENET

597 ×0.8

1.4k ×2.3

GENET

Citations per year, relative to Ilya V. Ulasov Ilya V. Ulasov (= 1×) peers Atique U. Ahmed

Countries citing papers authored by Ilya V. Ulasov

Since Specialization

Citations

This map shows the geographic impact of Ilya V. Ulasov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilya V. Ulasov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilya V. Ulasov more than expected).

Fields of papers citing papers by Ilya V. Ulasov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilya V. Ulasov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilya V. Ulasov. The network helps show where Ilya V. Ulasov may publish in the future.

Co-authorship network of co-authors of Ilya V. Ulasov

This figure shows the co-authorship network connecting the top 25 collaborators of Ilya V. Ulasov. A scholar is included among the top collaborators of Ilya V. Ulasov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilya V. Ulasov. Ilya V. Ulasov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ulasov, Ilya V., et al.. (2024). Idiopathic Pulmonary Fibrosis: Where do We Stand and How Far to Go?. Discovery Medicine. 36(180). 22–22. 5 indexed citations

Kumar, Naveen, Sanjeev Kumar, Alok Shukla, et al.. (2024). Mitochondrial-mediated apoptosis as a therapeutic target for FNC (2′-deoxy-2′-b-fluoro-4′-azidocytidine)-induced inhibition of Dalton’s lymphoma growth and proliferation. Discover Oncology. 15(1). 16–16. 8 indexed citations

Kalinin, Stanislav, et al.. (2023). Carbonic Anhydrase Inhibitors Induce Ferroptosis through Inhibition of AKT/FTH1 Signaling in Ewing Sarcoma Tumor Cells. Cancers. 15(21). 5225–5225. 5 indexed citations

Шепелев, М. В., et al.. (2023). Advances of Genome Editing with CRISPR/Cas9 in Neurodegeneration: The Right Path towards Therapy. Biomedicines. 11(12). 3333–3333. 10 indexed citations

Schroeder, Brett, et al.. (2023). Ewing sarcoma treatment: a gene therapy approach. Cancer Gene Therapy. 30(8). 1066–1071. 4 indexed citations

Timashev, Peter, et al.. (2022). To Explore the Stem Cells Homing to GBM: The Rise to the Occasion. Biomedicines. 10(5). 986–986. 8 indexed citations

Решетов, И. В., et al.. (2022). Imaging Hallmarks of Sarcoma Progression Via X-ray Computed Tomography: Beholding the Flower of Evil. Cancers. 14(20). 5112–5112.

Ulasov, Ilya V., Anton V. Borovjagin, Jawad Fares, et al.. (2020). MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases. Cancer Letters. 481. 24–31. 16 indexed citations

Kaverina, Natalya, Anton V. Borovjagin, А. И. Карселадзе, et al.. (2018). Tamoxifen overrides autophagy inhibition in Beclin-1-deficient glioma cells and their resistance to adenovirus-mediated oncolysis via upregulation of PUMA and BAX. Oncogene. 37(46). 6069–6082. 24 indexed citations

10.

Kim, Julius W., J. Robert Kane, Wojciech K. Panek, et al.. (2018). A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model. Neurotherapeutics. 15(4). 1127–1138. 21 indexed citations

11.

Platonov, М. E., Anton V. Borovjagin, Natalya Kaverina, et al.. (2017). KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro. Cancer Letters. 417. 75–88. 20 indexed citations

12.

Ulasov, Ilya V., et al.. (2017). Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1868(1). 273–276. 18 indexed citations

13.

Cobbs, Charles, et al.. (2016). Cytomegalovirus as an oncomodulatory agent in the progression of glioma. Cancer Letters. 384. 79–85. 41 indexed citations

14.

Ulasov, Ilya V., et al.. (2015). INHIBITION OF MT1-MMP (MMP14) IMPROVES ANT-GLIOMA EFFECT OF COMBINATION: TEMOZOLOMIDE-IONIZING RADIATION IN THE GLIOBLASTOMA CANCER CELLS. Russian Journal of Biotherapy. 14(2). 53–58. 1 indexed citations

15.

Thaçi, Bart, et al.. (2012). Anti-angiogenic therapy increases intratumoral adenovirus distribution by inducing collagen degradation. Gene Therapy. 20(3). 318–327. 29 indexed citations

16.

Sengupta, Sadhak, Ilya V. Ulasov, Bart Thaçi, Atique U. Ahmed, & Maciej S. Lesniak. (2011). Enhanced Transduction and Replication of RGD-Fiber Modified Adenovirus in Primary T Cells. PLoS ONE. 6(3). e18091–e18091. 11 indexed citations

17.

Ahmed, Atique U., Cleo E. Rolle, Matthew A. Tyler, et al.. (2010). Bone Marrow Mesenchymal Stem Cells Loaded With an Oncolytic Adenovirus Suppress the Anti-adenoviral Immune Response in the Cotton Rat Model. Molecular Therapy. 18(10). 1846–1856. 58 indexed citations

18.

Ulasov, Ilya V., Adam M. Sonabend, Sumon Nandi, et al.. (2009). Combination of adenoviral virotherapy and temozolomide chemotherapy eradicates malignant glioma through autophagic and apoptotic cell death in vivo. British Journal of Cancer. 100(7). 1154–1164. 58 indexed citations

19.

Ulasov, Ilya V., et al.. (2008). Evaluation of E1A double mutant oncolytic adenovectors in anti‐glioma gene therapy. Journal of Medical Virology. 80(9). 1595–1603. 16 indexed citations

20.

Ulasov, Ilya V., et al.. (2007). Fiber‐knob modifications enhance adenoviral tropism and gene transfer in malignant glioma. The Journal of Gene Medicine. 9(3). 151–160. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact